Evidence map›Paper›PMID 41928236›Full record

ArticleRespiratory research2026

Longitudinal dynamics and site-specific recovery of the human respiratory microbiome following smoking cessation.

Silvia Gschwendtner, Draginja Kovacevic, Karoline I Gaede, Christian Herzmann, Jörg Overmann, Michael Schloter, Susanne Krauss-Etschmann

Abstract readMulticenter Study
In one paragraph

Article in Respiratory research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Silvia GschwendtnerResearch Unit of Comparative Microbiome Analysis, Helmholtz Munich, German Research Center for Environmental Health, Neuherberg, Germany. silvia.gschwendtner@helmholtz-munich.de.
Draginja KovacevicEarly Life Origins of Chronic Lung Disease, Research Center Borstel - Leibniz Lung Center, Airway Research Center North (ARCN), German Center for Lung Research (DZL), Borstel, Germany.
Karoline I GaedeBioMaterialBank Nord, Research Center Borstel - Leibniz Lung Center, Borstel, Airway Research Center North (ARCN), German Center for Lung Research (DZL), Borstel, Germany.
Christian HerzmannPublic Health Authority Stormarn, Environmental Health Department, Bad Oldesloe, Germany.
Jörg OvermannBavarian State Collections of Natural History, Munich, Germany.
Michael SchloterResearch Unit of Comparative Microbiome Analysis, Helmholtz Munich, German Research Center for Environmental Health, Neuherberg, Germany.
Susanne Krauss-EtschmannEarly Life Origins of Chronic Lung Disease, Research Center Borstel - Leibniz Lung Center, Airway Research Center North (ARCN), German Center for Lung Research (DZL), Borstel, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe human respiratory tract harbours diverse microbial communities crucial for health, but their dynamics during environmental perturbations like smoking remain poorly understood. While smoking is a major risk factor for various diseases, its compartment-specific effects on the respiratory microbiome and potential recovery following cessation have not been fully elucidated. Here, we present a longitudinal, multi-site study of respiratory microbiome dynamics in smokers undergoing cessation, benchmarked against healthy never-smokers.

methodsUsing standardized sampling of the anterior nares, oropharynx, and bronchoalveolar lavage (BAL), combined with 16S rRNA gene amplicon sequencing and rigorous contamination controls, we characterized community composition, diversity, inter-individual variability, and microbial interactions across airway compartments.

resultsSmokers exhibited pronounced microbiome alterations: nasal richness increased, while lung richness and core taxa were decreased. Smoking-induced changes were compartment-specific and most pronounced in nose and lung. The degree of individual-specific differences in community structure was elevated in smokers and correlated with smoking history. Short-term cessation (6 weeks) led to minor shifts in genus abundance but increased similarity between oropharyngeal and lung communities, whereas long-term cessation (1 year) resulted in partial restoration, particularly in lung and nasal microbiomes. Some genera, including Haemophilus and Prevotella_7, showed persistent alterations, suggesting lasting smoking effects. Network analyses revealed that smoking disrupted microbial co-occurrence and reduced community connectivity, whereas cessation partially restored interaction networks, with central taxa remaining altered and dynamics differing between oropharynx and lung, reflecting different underlying ecological assembly processes. Recovery trajectories were highly individualized, with lung microbiomes influenced by deterministic processes and upper airway microbiomes shaped by stochastic factors, explaining site-specific responses and the persistence of personalized microbial signatures.

conclusionThese results provide the first time-resolved, multi-compartment characterization of respiratory microbiome recovery after smoking cessation, revealing that smoking leaves lasting, site-specific imprints on airway microbial communities and interactions. Our findings underscore the need for individual and compartment-specific approaches when designing microbiome-based interventions to support respiratory health.

Indexed as

LungMicrobiotaRespiratory SystemSmokingSmoking CessationAdultBronchoalveolar Lavage FluidFemaleHumansLongitudinal StudiesMaleMiddle AgedDysbiosisMicrobiomeRespiratory systemSmokingSmoking cessation

Identifiers

PMID41928236
PMCPMC13064275

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.